Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07296627
What this trial is testing

Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Newly Diagnosed Multiple Myeloma (NDMM)
Peking University People's Hospital 500
Testing effectiveness (Phase 2)Looking for participantsNCT07638683
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).

Who this might be right for
Multiple MyelomaAL Amyloidosis
Shanghai Zhongshan Hospital 30
Large-scale testing (Phase 3)Study completedNCT02495922
What this trial is testing

A Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma

Who this might be right for
Multiple Myeloma
University of Heidelberg Medical Center 564
Testing effectiveness (Phase 2)Study completedNCT01190787
What this trial is testing

Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 150
Large-scale testing (Phase 3)Study completedNCT00950768
What this trial is testing

Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients

Who this might be right for
Multiple MyelomaDiagnosis
Azienda Ospedaliera San Giovanni Battista 298
Testing effectiveness (Phase 2)Ended earlyNCT02720510
What this trial is testing

A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals 6
Testing effectiveness (Phase 2)Looking for participantsNCT06376526
What this trial is testing

IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dickran Kazandjian, MD 150
Testing effectiveness (Phase 2)Study completedNCT02219178
What this trial is testing

Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Cancer Trials Ireland 42
Large-scale testing (Phase 3)Looking for participantsNCT07764978
What this trial is testing

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Who this might be right for
Newly Diagnosed Multiple Myeloma
AstraZeneca 750
Early research (Phase 1)Study completedNCT01440582
What this trial is testing

Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 77
Not applicableStudy completedNCT03200626
What this trial is testing

Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaBone Marrow Transplant Complications
Medical College of Wisconsin 750
Testing effectiveness (Phase 2)Study completedNCT02649790
What this trial is testing

Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)Metastatic Colorectal Cancer (mCRC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more
Karyopharm Therapeutics Inc 277
Testing effectiveness (Phase 2)Ended earlyNCT02002598
What this trial is testing

Carfilzomib With Bendamustine and Dexamethasone in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Suzanne Lentzsch, MD 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT07671287
What this trial is testing

GMMG-HD11/DSMM XXI/64007957MMY3010

Who this might be right for
Multiple Myeloma
University of Heidelberg Medical Center 399
Testing effectiveness (Phase 2)Study completedNCT01057225
What this trial is testing

Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma

Who this might be right for
Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Mayo Clinic 64
Not applicableStudy completedNCT01809717
What this trial is testing

Multiple Myeloma and Exercise

Who this might be right for
Newly Diagnosed Multiple Myeloma
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)UnknownNCT02624440
What this trial is testing

Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaInfection
Henrik Gregersen 300
Testing effectiveness (Phase 2)Study completedNCT00538733
What this trial is testing

Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 26
Large-scale testing (Phase 3)Study completedNCT00689936
What this trial is testing

Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 1,623
Large-scale testing (Phase 3)Ended earlyNCT00984828
What this trial is testing

Randomized Study of Velcade-based Regimen With Autologous Stem Cell Transplantation in Newly-diagnosed Myeloma Patients

Who this might be right for
Multiple Myeloma
Shanghai Jiao Tong University School of Medicine 23
Next Page